Evidence map›Paper›PMID 40459248›Full record

ArticleAndrology2026

Cryptorchidism: Novel genetic insights into CCDC149 mutations.

Shengrong Du, Shan Xu, Lei Yang, Yan Ye, Yuhan Wu, Ziyun Xiao, Xiuqing Dong, Wenliang Yao, Hua Li

Abstract readCase Reports
In one paragraph

Article in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shengrong DuKey Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Shan XuFujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, Fujian, China.
Lei YangCenter of Reproductive Medicine, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
Yan YeGanzhou Key Laboratory of Molecular Medicine, the Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, Jiangxi Province, China.
Yuhan WuKey Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Ziyun XiaoKey Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Xiuqing DongThe United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Wenliang YaoNanchang Reproductive Hospital, Jiangxi University of Chinese Medicine Affiliated Reproductive Hospital, Andrology, Nanchang, Jiangxi Province, China.
Hua LiKey Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.

Funding

Joint Funds for the innovation of science and Technology, Fujian province 2023Y9383Joint Funds for the innovation of science and Technology, Fujian province 2024Y9090Natural Science Foundation of Fujian Province 2021J01681
6 · The paper itself

Abstract

backgroundCryptorchidism, characterized by the failure of one or both testes to descend into the scrotum, is a common congenital condition that can lead to infertility and increased risk of testicular cancer. CCDC149, a coiled-coil domain-containing protein, has been implicated in various developmental processes, but its role in the male reproductive system remains unexplored.

objectiveThis study aims to investigate the role of CCDC149 mutations in the development of bilateral cryptorchidism and to elucidate the underlying molecular mechanisms. MATERIALS AND

methodsWe conducted a whole-exome sequencing of an 8-year-old boy diagnosed with bilateral cryptorchidism, revealing a mutation in the CCDC149 gene. To further explore the functional implications of this mutation, we utilized CRISPR/Cas9 technology to generate Ccdc149 knockout mice. The phenotypic characteristics of these mice were assessed, focusing on testicular descent and sperm morphology. Additionally, single-cell RNA sequencing was performed to analyze the expression of genes associated with CCDC149, including anti-Müllerian hormone (AMH) and muscle-related factors.

resultsThe Ccdc149 knockout mice exhibited significant phenotypic traits consistent with cryptorchidism, including undescended testes and oligoasthenoteratozoospermia. Single-cell RNA sequencing analysis revealed altered expression patterns of AMH and several muscle-related genes, suggesting a potential regulatory interaction between CCDC149, AMH, and muscle development factors in the context of testicular descent. DISCUSSION: Our findings provide novel genetic insights into the role of CCDC149 mutations in cryptorchidism. The observed phenotypic characteristics in the knockout mice, along with the gene expression analysis, indicate that CCDC149 may be crucial for normal testicular descent through its interaction with AMH and muscle-related factors. These results highlight the importance of further research into the molecular mechanisms underlying cryptorchidism, which could lead to improved diagnostic and therapeutic strategies for affected individuals.

Indexed as

CryptorchidismAnimalsChildExome SequencingHumansMaleMiceMice, KnockoutMutationPhenotypeTestisCCDC149cryptorchidismgubernaculumtesticular descent

Identifiers

PMID40459248
PMCPMC13266423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.